Leadership transition at biocrates following Bruker acquisition

Strengthening multiomics innovation through integration and continuity

biocrates life sciences ag has announced a leadership change following its recent acquisition by Bruker Corporation. After five years as CEO, Moritz Seuster will step down, having led the company through a successful digital transformation and the launch of its next-generation metabolomics kit. CMO Sebastian Gottfried has been appointed Site Manager and will oversee the integration with Bruker. Going forward, biocrates will focus on expanding into the multiomics market and driving innovation across mass spectrometry platforms.

biocrates becomes part of Bruker Corporation

A new chapter in quantitative metabolomics

We are excited to share that biocrates life sciences ag has joined Bruker Corporation, marking a major milestone in the evolution of quantitative metabolomics. As a global leader in mass spectrometry-based metabolite and lipid profiling, biocrates will continue to drive innovation and accessibility in multiomics – now with the expanded support and reach of Bruker. This partnership strengthens our shared mission to deliver reproducible, standardized solutions for precision research worldwide.

Transforming medicine with metabolomics

Virtual event | July 15, 2025 | 04:00 pm CEST

Join our upcoming webinar to explore how the MxP® Quant 1000 is driving biomarker discovery and enabling personalized medicine. Experts will present real-world insights from HIV and other studies, highlighting the impact of this powerful kit in clinical research.

MetIDQ support ending soon

Migrate to WebIDQ now

Our legacy software MetIDQ will reach the end of its support lifecycle on December 31, 2025.
If you’re still using MetIDQ, now is the time to migrate to WebIDQ – our cloud-based workflow and analysis software. Click the button for full details and support information.

🎧 The Metabolomist podcast 🎧

Episode 3 – Exposomics & 5P medicine

In this episode, Alice Limonciel and Gary Miller discuss the synergies of exposomics and metabolomics, the next frontier in multiomics integration, and how exposomics promises to bolster all 5Ps and the future of medicine.

Tech note MxP® Quant 1000 kit

Coverage and precision across biological matrices

In this technical note the MxP® Quant 1000 kit is evaluated across plasma, urine, and feces, with high precision, robust detection, and matrix-specific methods. The kit offers unparalleled flexibility and coverage for quantitative targeted metabolomics. Combined with MetaboINDICATOR, the MxP® Quant 1000 delivers up to 1,881 potential biomarkers empowering multiomics research.

Transform medicine with metabolomics

Predictive medicine – part 2 of 5

In this five-part blog series, we explore the role of metabolomics in 5P medicine. This second installment highlights how screening samples with broad metabolomics panels and leveraging data with knowledge-driven tools leads to the translation of metabolomics insights into innovative strategies for predictive medicine.

Transform medicine with metabolomics

Preventive medicine – part 1 of 5

Metabolomics is poised to revolutionize medicine through 5P approach, which encompasses preventive, predictive, precise, participatory and population-based healthcare strategies. This first article in a five-part series focuses on prevention, illustrating how metabolomics aids in detecting early disease risks and facilitates personalized lifestyle and dietary interventions.

Strategic collaboration with Platomics

A game-changer for the adoption of metabolomics

We are excited to announce a collaboration with Platomics to streamline metabolomics adoption in laboratories. Integrating biocrates’ kits into the PlatoX® platform simplifies quality assurance, ensuring reproducible results with less effort. Laboratories can seamlessly incorporate regulatory guidance into workflows, from sample preparation to data analysis, accelerating standardized and compliant research.

Partnership to make metabolomics accessible

biovis and biocrates launch personalized health test

With Prevent360, biovis and biocrates enable individuals to monitor 75 key health parameters, backed by personalized recommendations for nutrition, exercise, and overall wellness. This breakthrough reflects our shared passion for innovation and our vision of giving people the knowledge they need to proactively manage their health.

Nutrition and consumer well-being

How metabolomics drives personalized medicine

Metabolomics improves precision nutrition by uncovering real-time connections between diet and health. Metabolic biomarkers enable objective, personalized advice on diet and other lifestyle factors, unlike error-prone food journals. This article explores how metabolic profiling enhances the accuracy of nutrition and health assessments. It also discusses integration of metabolomics into consumer tests using at-home sampling to support health monitoring.